One World Products (OWPC) Shares Outstanding (Diluted Average) (2021 - 2025)
One World Products (OWPC) recorded quarterly Shares Outstanding (Diluted Average) of $118.8 million in Q3 2025, up 0.71% quarter-over-quarter from $117.9 million in Q2 2025, and up 4.54% on a YoY basis from $113.6 million in Q3 2024.
One World Products (OWPC) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends
One World Products' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $118.8 million for Q3 2025.
- In Q3 2025, Shares Outstanding (Diluted Average) rose 4.54% year-over-year to $118.8 million; the TTM figure through Sep 2025 stood at $118.8 million (up 4.54% YoY), while the FY2024 annual figure was $107.0 million, up 45.87% from the prior year.
- Shares Outstanding (Diluted Average) was $118.8 million for Q3 2025 at One World Products, up from $117.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $118.8 million in Q3 2025 to a low of $56.1 million in Q1 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $82.5 million across 5 years, with a median of $70.5 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) jumped 59.05% in 2024, then rose 4.54% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $61.7 million in 2021, then advanced by 7.35% to $66.2 million in 2022, then climbed by 10.79% to $73.3 million in 2023, then soared by 45.87% to $107.0 million in 2024, then gained by 11.03% to $118.8 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $118.8 million (Q3 2025), $117.9 million (Q2 2025), and $117.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | One World Products | - | - | 48,591.00 | 118.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 118.78 Mn |
| Jun 30, 2025 | 117.94 Mn |
| Mar 31, 2025 | 117.24 Mn |
| Dec 31, 2024 | 106.97 Mn |
| Sep 30, 2024 | 113.62 Mn |
| Jun 30, 2024 | 99.75 Mn |
| Mar 31, 2024 | 86.93 Mn |
| Dec 31, 2023 | 73.33 Mn |
| Sep 30, 2023 | 71.44 Mn |
| Jun 30, 2023 | 69.66 Mn |
| Mar 31, 2023 | 68.70 Mn |
| Dec 31, 2022 | 66.19 Mn |
| Sep 30, 2022 | 66.08 Mn |
| Jun 30, 2022 | 65.86 Mn |
| Mar 31, 2022 | 65.61 Mn |
| Sep 30, 2021 | 61.66 Mn |
| Jun 30, 2021 | 58.72 Mn |
| Mar 31, 2021 | 56.11 Mn |